Alkem Laboratories Limited (BOM:539523)
5,168.65
+23.65 (0.46%)
At close: Nov 20, 2026
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 619.94 billion as of November 20, 2026. Its market cap has decreased by 9.42% in one year.
Market Cap
619.94B
Enterprise Value
600.75B
Revenue
156.32B
Global Rank
n/a
Country Rank
n/a
PE Ratio
29.89
ChartMarket Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 619.94B, an increase of 275.26%. That is a compound annual growth rate of 12.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 619.94B | -5.84% |
| Dec 31, 2025 | 658.38B | -2.26% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zydus Lifesciences | 1.20T |
| Cipla | 1.14T |
| Mankind Pharma | 1.09T |
| Aurobindo Pharma | 1.04T |
| Glenmark Pharmaceuticals | 745.12B |
| Alkem Laboratories | 616.84B |
| Gland Pharma | 549.80B |
| Ipca Laboratories | 465.04B |